Blood CEA levels for detecting recurrent colorectal cancer
BD Nicholson, B Shinkins, I Pathiraja… - Cochrane Database …, 2015 - cochranelibrary.com
Background Testing for carcino‐embryonic antigen (CEA) in the blood is a recommended
part of follow‐up to detect recurrence of colorectal cancer following primary curative …
part of follow‐up to detect recurrence of colorectal cancer following primary curative …
Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal …
ZS Dawood, L Alaimo, HA Lima, Z Moazzam… - Annals of Surgical …, 2023 - Springer
Background Almost one-third of colorectal cancer (CRC) patients experience recurrence
after resection; nevertheless, follow-up strategies remain controversial. We sought to …
after resection; nevertheless, follow-up strategies remain controversial. We sought to …
The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
Purpose Tumor recurrence of colorectal cancers (CRC) is generally followed up by analyses
of the serum carcinoembryonic antigen (CEA) levels. However, recent evidence suggests …
of the serum carcinoembryonic antigen (CEA) levels. However, recent evidence suggests …
[HTML][HTML] Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ …
W Wu, Z Zhang, XH Gao, Z Shen, Y Jing, H Lu, H Li… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Circulating tumor cells (CTC) are useful in early detection of colorectal cancer. This study
described a newly developed platform, integrated subtraction enrichment and …
described a newly developed platform, integrated subtraction enrichment and …
[HTML][HTML] Polymeric nanoparticles approach and identification and characterization of novel biomarkers for colon cancer
R Garg, M Gaur, BG Prajapati, G Agrawal… - Results in …, 2023 - Elsevier
The need for novel approaches to the treatment of colon cancer, a common and deadly
disease, is universal. In this compilation, we look at how polymeric nanoparticles (Polymeric …
disease, is universal. In this compilation, we look at how polymeric nanoparticles (Polymeric …
Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic …
M Ishizuka, H Nagata, K Takagi, Y Iwasaki… - Annals of surgical …, 2012 - Springer
Background Although carcinoembryonic antigen (CEA) is a valuable indicator for estimating
the progression of colorectal cancer (CRC), some patients with advanced CRC show no …
the progression of colorectal cancer (CRC), some patients with advanced CRC show no …
[HTML][HTML] Value of 18F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations
Y Zhang, B Feng, GL Zhang, M Hu, Z Fu… - World Journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To evaluate the value of positron emission tomography (PET)/computerized
tomography (CT) in surveillance of colorectal cancer (CRC) patients with different …
tomography (CT) in surveillance of colorectal cancer (CRC) patients with different …
Survival outcomes in asymptomatic patients with normal conventional imaging but raised carcinoembryonic antigen levels in colorectal cancer following positron …
K Khan, A Athauda, K Aitken, D Cunningham… - The …, 2016 - academic.oup.com
Background. This study had two aims:(a) to evaluate the utility of fluorine 18-
fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) …
fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) …
Clinical usefulness of serum CYFRA 21–1 in patients with colorectal cancer
JH Lee - Nuclear medicine and molecular imaging, 2013 - Springer
Purpose Among diverse tumor markers, pretreatment evaluation and follow-up detection of
recurrence in colorectal cancer are generally evaluated by serum carcinoembryonic antigen …
recurrence in colorectal cancer are generally evaluated by serum carcinoembryonic antigen …
Follow-Up 18F-FDG PET/CT Versus Contrast-Enhanced CT After Ablation of Liver Metastases of Colorectal Carcinoma—a Cost-Effectiveness Analysis
ML Schnitzer, MF Froelich, FG Gassert, T Huber… - Cancers, 2020 - mdpi.com
Purpose: After a percutaneous ablation of colorectal liver metastases (CRLM), follow-up
investigations to evaluate potential tumor recurrence are necessary. The aim of this study …
investigations to evaluate potential tumor recurrence are necessary. The aim of this study …